Clinical Trial Update: A Rollover Study of CC-122 [Phase 1]

View source ↗

Summary

Rollover Phase 1 trial update for CC-122 in Non-Hodgkin Lymphoma; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• CC-122

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Non-Hodgkin Lymphoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING